Baricitinib Development as a Lupus Treatment Discontinued
January 28, 2022
The Lupus Research Alliance is disappointed that the Phase 3 development program of OLUMIANT® (baricitinib) as a...
Lilly
Promising News from Major Medical Meeting, EULAR
Updated June 5, 2020
One of the largest meetings for rheumatologists went virtual this year to enable scientists from around...
Updates in Lupus Clinical Research from the LUPUS 2019 Meeting
April 11, 2019
The Lupus Research Alliance is pleased to share the results from four clinical trials presented at LUPUS...